Companies
West Pharmaceutical Services
Medical devicesExton, PennsylvaniaWSTAbout 10,800 employees
More about West Pharmaceutical Services
Maker of stoppers, seals, syringe components and delivery devices used to package and administer injectable drugs
Revenue
$3.07B
Fiscal 2025, up about 6%
Employees
About 10,800
As of December 2025
Stock
WST
New York Stock Exchange
Headquarters
Exton, Pennsylvania
CEO
Michel Lagarde
Since August 2026
Main businessesProprietary Products, Contract-Manufactured Products
Current strategyGrowing its High Value Product Components for injectable medicines under a new CEO who succeeded Eric Green
CompetitorsStevanato Group, Becton Dickinson, Aptar
Related companiesBDThermo Fisher ScientificEli Lilly
Checked October 11, 2026 · Sources: sec.gov, sec.gov (2), sec.gov (3)
Be the first to post about West Pharmaceutical Services
No one has started a discussion here yet. Yours is anonymous and appears right away, and we don’t store who wrote it.
Or follow West Pharmaceutical Services to see the first post in your watchlist.
Follow West Pharmaceutical Services in a feed reader, no account needed: RSS feed